Shield Therapeutics
Bryon Kallert is a finance professional with extensive experience in financial planning and analysis. Currently serving as Senior Director of FP&A at Shield Therapeutics plc since December 2021, Kallert previously held multiple positions at PwC from January 2014 to December 2021, including Senior Manager and Manager in Finance Effectiveness Advisory focusing on the healthcare sector. Earlier experience includes a role as Commercial Assurance Senior at Ernst & Young and an internship at Merrill Lynch. Kallert is a Certified Public Accountant and holds a Bachelor of Business Administration degree in Accounting and Finance from Questrom School of Business, Boston University.
This person is not in any teams
This person is not in any offices
Shield Therapeutics
1 followers
Shield Therapeutics is a specialty pharmaceutical company focused on the development and commercialisation of late‑stage, hospital‑focused pharmaceuticals.